Craig Reynolds - Masimo Independent Director
| MASI Stock | USD 137.00 0.75 0.55% |
Director
Mr. Craig B. Reynolds is an Independent Director of Masimo Corporationration Mr. Reynolds is currently Chief Executive Officer and a director of Cereve, Inc., a medical company engaged in resolving insomnia issues. Prior to joining Cereve, Mr. Reynolds served as Chief Operating Officer of PhilipsRespironics Home Health Solutions, a subsidiary of Philips, from 2008 to 2010. Prior to PhilipsRespironics, Mr. Reynolds was the Chief Operating Officer and a board member of Respironics, Inc., a company that develops, manufactures and markets medical devices worldwide, from 1998 to 2008. From 1993 to 1998, Mr. Reynolds was with Healthdyne Technologies, Inc., a medical device company, serving for five years as Chief Executive Officer and director. From 1981 through 1992, Mr. Reynolds was with Healthdyne, Inc. in the positions of Executive V.P., President of Healthdyne Cardiovascular Division and President of Healthdyne Homecare Division . From 2008 through 2014, Mr. Reynolds served as a director of Symmetry Medical, Inc., most recently as Chairman of the Board. He also served as Chairman of the Board of Symmetry Surgical, Inc. from 2014 through 2016 since 2014.
| Age | 68 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Address | 52 Discovery, Irvine, CA, United States, 92618 |
| Phone | 949 297 7000 |
| Web | https://www.masimo.com |
Craig Reynolds Latest Insider Activity
Tracking and analyzing the buying and selling activities of Craig Reynolds against Masimo stock is an integral part of due diligence when investing in Masimo. Craig Reynolds insider activity provides valuable insight into whether Masimo is net buyers or sellers over its current business cycle. Note, Masimo insiders must abide by specific rules, including filing SEC forms every time they buy or sell Masimo'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Craig Reynolds over a week ago Disposition of 40000 shares by Craig Reynolds of Masimo at 136.1654 subject to Rule 16b-3 |
Masimo Management Efficiency
The company has return on total asset (ROA) of 0.0293 % which means that it generated a profit of $0.0293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0603 %, meaning that it created $0.0603 on every $100 dollars invested by stockholders. Masimo's management efficiency ratios could be used to measure how well Masimo manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Masimo's Return On Tangible Assets are decreasing as compared to previous years. The Masimo's current Return On Capital Employed is estimated to increase to 0.14, while Return On Assets are projected to decrease to 0.04. As of now, Masimo's Total Current Assets are increasing as compared to previous years. The Masimo's current Intangible Assets is estimated to increase to about 1.3 B, while Non Currrent Assets Other are forecasted to increase to (481.5 M).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mudit Jain | Inspire Medical Systems | 49 | |
| Brian Concannon | CONMED | 62 | |
| Surbhi Sarna | Penumbra | 34 | |
| Jerry Griffin | Inspire Medical Systems | 76 | |
| Neil Luke | Inspire Medical Systems | N/A | |
| Howard Greene | Tandem Diabetes Care | 75 | |
| Jay Skyler | DexCom Inc | 71 | |
| Eric Topol | DexCom Inc | 63 | |
| James Mullen | Insulet | 58 | |
| Jerome Lande | CONMED | 45 | |
| Martha Aronson | CONMED | 53 | |
| Janet Leeds | Penumbra | 58 | |
| Gilbert Kliman | Glaukos Corp | 61 | |
| Jesse Treu | Tandem Diabetes Care | 67 | |
| David Hoffmeister | Glaukos Corp | 66 | |
| Shelley Broader | Inspire Medical Systems | 56 | |
| Aimee Weisner | Glaukos Corp | 51 | |
| Joseph Zakrzewski | Insulet | 53 | |
| Harpreet Grewal | Penumbra | 53 | |
| Nicholas Augustinos | DexCom Inc | 59 | |
| Alfred Novak | LivaNova PLC | 70 | |
Management Performance
| Return On Equity | 0.0603 | ||||
| Return On Asset | 0.0293 |
Masimo Leadership Team
Elected by the shareholders, the Masimo's board of directors comprises two types of representatives: Masimo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Masimo. The board's role is to monitor Masimo's management team and ensure that shareholders' interests are well served. Masimo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Masimo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yongsam Lee, CIO and Executive VP | ||
| Micah Young, CFO, Executive Vice President | ||
| Tao Levy, Executive Vice President - Business Development | ||
| David Ramshorst, Chief Accounting Officer | ||
| Rick Fishel, President of Worldwide OEM Bus. and Blood Management | ||
| Julie Shimer, Director | ||
| H Cohen, Director | ||
| Joseph Kiani, Chairman of the Board, CEO | ||
| Paul Jansen, Executive Vice President - Marketing and Clinical Development | ||
| Bilal Muhsin, Executive Vice President Engineering, Marketing & Regulatory Affairs | ||
| Adam Mikkelson, Director | ||
| Tom McClenahan, Executive Vice President General Counsel | ||
| Steven Barker, Chairman Officer | ||
| Craig Reynolds, Independent Director | ||
| Mark Raad, CFO and Executive VP of Fin. | ||
| Sanford Fitch, Independent Director | ||
| Thomas Harkin, Director | ||
| Eli Kammerman, Investor Relations Officer | ||
| Jack Lasersohn, Independent Director | ||
| Jon Coleman, President - Worldwide Sales, Professional Services and Medical Affairs | ||
| Joe Kiani, Founder, Chairman and CEO | ||
| John Coleman, President - Worldwide Sales, Professional Services and Medical Affairs | ||
| Thomas McClenahan, General VP | ||
| Paul Hataishi, Senior Officer | ||
| Anand Sampath, Ex Research |
Masimo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Masimo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0603 | ||||
| Return On Asset | 0.0293 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 8.02 B | ||||
| Shares Outstanding | 52.78 M | ||||
| Shares Owned By Insiders | 7.64 % | ||||
| Shares Owned By Institutions | 96.01 % | ||||
| Number Of Shares Shorted | 4.04 M | ||||
| Price To Earning | 35.69 X |
Masimo Investors Sentiment
The influence of Masimo's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Masimo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Masimo's public news can be used to forecast risks associated with an investment in Masimo. The trend in average sentiment can be used to explain how an investor holding Masimo can time the market purely based on public headlines and social activities around Masimo. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Masimo's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Masimo's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Masimo's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Masimo.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Masimo in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Masimo's short interest history, or implied volatility extrapolated from Masimo options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Masimo. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Masimo Stock please use our How to Invest in Masimo guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Masimo Stock analysis
When running Masimo's price analysis, check to measure Masimo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Masimo is operating at the current time. Most of Masimo's value examination focuses on studying past and present price action to predict the probability of Masimo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Masimo's price. Additionally, you may evaluate how the addition of Masimo to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Masimo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Masimo. If investors know Masimo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Masimo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Earnings Share 1.51 | Revenue Per Share 38.79 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0293 |
The market value of Masimo is measured differently than its book value, which is the value of Masimo that is recorded on the company's balance sheet. Investors also form their own opinion of Masimo's value that differs from its market value or its book value, called intrinsic value, which is Masimo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Masimo's market value can be influenced by many factors that don't directly affect Masimo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Masimo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Masimo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Masimo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.